LINC 2021 programme


LINC 2021, the Leipzig Interventional Course, featured state-of-the-art lectures and
more than 40 live cases were performed from leading interventional centers.

LINC 2021 does not have an extra live case guide, but all patient slides
are in the program as pdf downloads for your information.

LINC 2021 programme

Find all topics and speakers listed below.

Conference day 3

  • - , Main Arena 1

    LINC 2021 CONNECT – joint session with JET

    Moderator:
    Dierk Scheinert, Hiroyoshi Yokoi
    Panel:
    Kazushi Urasawa, Giancarlo Biamino, Ralf Langhoff
    1. -

      Live case transmission from Amagasaki

        Kansai Rosai Hospital Amagsaki - Live case center
    2. -

      CTO technique and the step-up PTA approach

        Kazushi Urasawa
    3. -

      Subintimal recanalization of peripheral occlusive disease with IVUS guided true lumen re-entry

        Igor Rafael Sincos
    4. -

      The challenge of treating multivessel disease to preserve future treatment options: a case example

        Erwin Blessing
    5. -

      Japan update: optimal strategies for vessel preparation and DCB usage

        Daizo Kawasaki
    6. -

      Update on Paclitaxel safety from the results of Japanese patients analysis

        Masato Nakamura
    7. -

      Treatment strategy for fempop critical limb-threatening ischemia

        Tatsuya Nakama
    8. -

      Live case transmission from Leipzig

        Universitätsklinikum Leipzig, Abt. Angiologie - Live case center
    9. -

      4F endovascular treatment is as safe and effective as 6F with no need for VCD: full cohort analysis of the BIO4AMB multicenter trial

        Jos van den Berg
    10. -

      IVUS guided atherectomy and DCB of calcified infrapopliteal disease: PRESTIGE trial update

        Michael Lichtenberg
    11. -

      Rotational atherectomy in common femoral artery – endovascular treatment in a difficult-to-treat 'surgical' territory

        Grigorios Korosoglou
  • - , LINC Studio

    LINC Studio – Start into day 3

    Moderator:
    Dierk Scheinert, Sabine Steiner
  • - , Main Arena 1

    Redefining vascular treatment strategy for AVF and AVG: a deep dive into Sirolimus coated balloon

    Chairman:
    Konstantinos Katsanos
    Moderator:
    Tjun Tang
    Panel:
    Ounali Jaffer, Tze Tec Chong
    1. -

      Treatment of AVF Stenosis with DCBs: advantages of Sirolimus over Paclitaxel

        Aloke Finn
    2. -

      MagicTouch use at the graft-vein junction in thrombosed AVGs – 1 year outcome data

        Chieh Suai Tan
    3. -

      MATILDA trial 1 year outcomes

        Tjun Tang
    4. -

      AVF case transmission from Singapore General Hospital

        Tjun Tang, Tze Tec Chong
    5. -

      AVG case transmission from Singapore General Hospital

        Chieh Suai Tan
    6. -

      Case discussion

    7. -

      Discussion and conclusion

  • - , Main Arena 2

    Guide wires: You know your skills…do you know your tools?

    1. -

      Live introduction

        Andrej Schmidt
    2. -

      History of Abbott wires

        Jonathan Durcan
    3. -

      Understanding the technical characteristics of GW

        Andrej Schmidt
    4. -

      Panel discussion

    5. -

      Case example

        Lieven Maene, Jonathan Durcan
    6. -

      Q&A, discussion, and conclusion

  • - , LINC Studio

    LINC Studio – Current status of carotid interventions – part I

    Moderator:
    Dierk Scheinert, Sabine Steiner
    Guest:
    E. Sebastian Debus, Alberto Cremonesi
  • - , Main Arena 1

    Innovative concepts in carotid revascularization

    Moderator:
    Alberto Cremonesi, Marc van Sambeek
    Panel:
    E. Sebastian Debus, Piero Montorsi, Horst Sievert
    1. -

      12 month results from a prospective real-world multicenter clinical practice of CAS using the CGuard Embolic Prevention system: the IRONGUARD 2 study

        Pasqualino Sirignano
    2. -

      Live case transmission from Berlin

        Sankt-Gertrauden-Hospital Berlin - Live case center
    3. -

      Interim 30 day safety outcomes in symptomatic and asymptomatic patients treated with the Roadsaver dual-layer micromesh carotid artery stent: evidence from a large multicentre European ROADSAVER study

        Ralf Langhoff
    4. -

      The safety and effectiveness of carotid revascularization with the Acculink stent and the CGuard stent. Independent randomized study

        Savr Bugurov
    5. -

      Proximal protection for carotid artery stenting: a preferred solution for all-comers

        Piero Montorsi
    6. -

      Carotid artery revascularization: a systematic review and meta-analysis comparing clinical outcomes of second vs. first generations stents and CEA

        Adam Mazurek
    7. -

      Proximal vs. distal protection for carotid artery stenting: a review of the data

        Eugenio Stabile
    8. -

      State of the art medical management of carotid artery disease in the post COMPASS and VOYAGER study era

        Raghu Kolluri
  • - , LINC Studio

    LINC Studio – Current status of carotid interventions – part II

    Moderator:
    Dierk Scheinert, Sabine Steiner
    Guest:
    E. Sebastian Debus, Alberto Cremonesi
  • - , Main Arena 1

    SYMPOSIUM: Roadsaver – the power of facts. Dual layer CAS and the growing body of new clinical evidence

    Moderator:
    Piero Montorsi
    Panel:
    Andrea Kahlberg, Piotr Odrowaz-Pieniazek, Stefan Müller-Hülsbeck
    1. -

      Introduction

        Piero Montorsi
    2. -

      The vascular surgeon’s perspective: Italian comparative experience of Roadsaver vs. other stents

        Andrea Kahlberg
    3. -

      Discussion

    4. -

      Carotid artery stenting with 300 Roadsaver stent implantations. Early and 4 year results

        Piotr Odrowaz-Pieniazek
    5. -

      Discussion

    6. -

      Roadsaver carotid artery stent for tandem lesions in acute ischemic stroke – the Flensburg experience

        Stefan Müller-Hülsbeck
    7. -

      Q&A, discussion, and closure

  • - , Main Arena 2

    DEEP DIVE SESSION: Venous interventions

    Moderator:
    Tobias Hirsch
    Panel:
    Rick de Graaf, Houman Jalaie
    1. -

      Economic burden of venous leg ulcers resulting from underlying deep vein disease, review of a 7 country cost analysis

        Raghu Kolluri
    2. -

      Interventional management of venous leg ulcers secondary to deep vein obstruction: rationale and design of the IGuideU randomized controlled trial

        Paul Gagne
    3. -

      Patient profile for iliofemoral venous obstruction: which ones require stenting?

        Erin Murphy
    4. -

      Hip biomechanics and venous stent durability testing

        Kush Desai
    5. -

      Deep venous stenting in the PTS patient

        Marta Ramírez Ortega
    6. -

      Extreme reinterventions for failed iliofemoral venous stents

        Rick de Graaf
    7. -

      Venous disorder case study: iliofemoral occlusion and venous reflux (deep, pelvic, and superficial)

        Marzia Lugli
    8. -

      The impact of simultaneous GSV and AASV treatment – the SYNCHRONOUS trial

        Tobias Hirsch
    9. -

      Pelvic venous insufficiency: causes classification, diagnosis, and treatment options

        Marta Ramírez Ortega
    10. -

      PCS case discussion

        David Beckett
    11. -

      Q&A, discussion, and conclusion

  • - , LINC Studio

    LINC Studio – What is best practice in carotid revascularization

    Moderator:
    Dierk Scheinert, Sabine Steiner
    Guest:
    Eugenio Stabile, Martin Storck, Ralf Langhoff
  • - , Main Arena 1

    LUNCH SYMPOSIUM: Sustained limus release will make a difference to your patients

    Moderator:
    Michael Lichtenberg, Ehrin Armstrong
    Panel:
    Tjun Tang, Marianne Brodmann
    1. -

      Introduction

        Ehrin Armstrong
    2. -

      STEP Up with SELUTION SLR

        Marianne Brodmann
    3. -

      Panel discussion

    4. -

      Importance of "No" Slow Flow Phenomena

        Tjun Tang
    5. -

      Panel discussion

    6. -

      Why to choose Sirolimus for my CLI patients?

        Michael Lichtenberg
    7. -

      Panel discussion

  • - , Main Arena 2

    LUNCH SYMPOSIUM: LINC and LEARN: the consistency of intravascular lithotripsy (IVL) across multiple vessel beds

    Moderator:
    Thomas Zeller
    Panel:
    Arne Schwindt, Francesco Liistro, George Adams
    1. -

      Introduction, IVL mechanism of action, and historical perspective

        Thomas Zeller
    2. -

      Insights from the DISRUPT PAD III RCT in severly calcified fempop lesions

        Arne Schwindt
    3. -

      DISRUPT PAD III observational study – below-the-knee subset

        George Adams
    4. -

      IVL – a reliable and efficacious vessel preparation strategy

        Francesco Liistro
    5. -

      Q&A, discussion, and conclusion

  • - , LINC Studio

    LINC Studio – The challenge of thrombotic and embolic lesions: do we need specific strategies?

    Moderator:
    Dierk Scheinert, Sabine Steiner
    Guest:
    Andrej Schmidt, Thomas Zeller, Jos van den Berg
  • - , Main Arena 1

    Peripheral clot management – a paradigm shift in arterial clot removal: surgery to endovascular

    Speaker:
    Gianmarco de Donato
    1. Peripheral clot management – a paradigm shift in arterial clot removal: surgery to endovascular

        Gianmarco de Donato
  • - , LINC Studio

    LINC Studio – What is best for in-stent-restenosis?

    Moderator:
    Dierk Scheinert, Sabine Steiner
    Guest:
    Andrej Schmidt, Thomas Zeller, Koen Deloose, Aloke Finn
  • - , Main Arena 1

    SYMPOSIUM: Spotlight on challenging lower limb cases: tips and tricks for success

    Moderator:
    Dierk Scheinert
    Panel:
    Bruno Freitas, Luis Palena, Marc Sirvent
    1. -

      No increase in all-cause mortality with paclitaxel devices used in lower limb arterial interventions - an interim analysis of SWEDEPAD RCT data

        Joakim Nordanstig
    2. -

      Recorded case presentation: the importance of vessel prep before DCB to fight against CLI recurrence

        Luis Palena
    3. -

      Recorded case: Chronic in-stent re-occlusion left SFA

        Andrej Schmidt
    4. -

      Recorded case: Rotarex™S: Rotational atherothrombectomy catheter for an extreme rescue of a previous iliofempop, endovascular treatment for CTLI

        Marc Sirvent
    5. -

      Q&A, discussion, and conclusion

  • - , LINC Studio

    LINC Studio

    Moderator:
    Dierk Scheinert, Sabine Steiner
  • - , Main Arena 1

    SYMPOSIUM: How predictability and evidence lead to proven patient outcomes

    Moderator:
    Michael Dake
    Panel:
    Thomas Zeller, Carlos Mena-Hurtado, Aloke Finn, Michel Bosiers
    1. -

      When the benefit of paclitaxel outweigh the risk

        Thomas Zeller
    2. -

      Prediction model for freedom from TLR from a multi-study analysis of long-term results with the Zilver PTX stent

        Michael Dake
    3. -

      How the prediction model impact my daily clinical practice

        Carlos Mena-Hurtado
    4. -

      Live case transmission from Leipzig

        Universitätsklinikum Leipzig, Abt. Angiologie - Live case center
    5. -

      Pre-clinical impact of Eluvia

        Aloke Finn
    6. -

      Clinical impact of Eluvia

        Michel Bosiers
    7. -

      Q&A, discussion, and conclusion

  • - , LINC Studio

    LINC Studio – The challenge of vessel calcification

    Moderator:
    Dierk Scheinert, Sabine Steiner
    Guest:
    Aloke Finn, Thomas Zeller, Andrej Schmidt
  • - , Main Arena 1

    CONNECT VIVA/LINC – Calcification: the last frontier in vascular therapy

    Moderator:
    Sean Lyden, Maureen Kohi
    Panel:
    Raghu Kolluri, Ehrin Armstrong
    1. -

      Why does it form, what is the pathophysiology and is there a medical treatment on the horizon?

        Raghu Kolluri
    2. -

      Calcium grading systems, which one is most accurate?

        Peter Schneider
    3. -

      What are the best tools to prepare the calcified artery? Atherectomy, serration angioplasty, scoring, lithotripsy

        Ehrin Armstrong
    4. -

      Panel discussion

    5. -

      Recorded case from Leipzig: 'Crack & Pave'-technique for extreme calcification

        Andrej Schmidt
    6. ADVICE ABOUT MANAGING CALCIFICATION IN DIFFERENT VASCULAR BEDS: VESSEL PREP, SCAFFOLDS, DRUG DELIVERY, AND OTHER ISSUES OF PROVIDING DEFINITIVE THERAPY IN THIS CHALLENGING SITUATION

    7. -

      Carotid

        Kenneth Rosenfield
    8. -

      Aortoiliac

        Saher Sabri
    9. -

      SFA-pop

        Niten Singh
    10. -

      Tibial and BTA

        Venita Chandra
    11. -

      Panel discussion

    12. -

      Live case transmission from Kingsport

        Wellmont CVA Heart & Vascular Institute Kingsport - Live case center
  • - , LINC Studio

    LINC Studio – Current practice with drug-eluting devices

    Moderator:
    Dierk Scheinert, Sabine Steiner
    Guest:
    Thomas Zeller, Andrej Schmidt
  • - , Main Arena 1

    VIVA/LINC – Joint session on the current status and future of drug-eluting therapies

    Moderator:
    Dierk Scheinert, Peter Schneider
    Panel:
    Andrew Holden, Marianne Brodmann, Robert Lookstein
    1. -

      Introduction by the moderators

        Dierk Scheinert, Peter Schneider
    2. -

      Insights on paclitaxel safety from the femoral-popliteal RCTs

        Peter Schneider
    3. -

      Insights on paclitaxel safety from femoral-popliteal real-world data

        Eric Secemsky
    4. -

      New insights from the interim safety analysis of the SWEDEPAD study

        Joakim Nordanstig
    5. -

      How does the Voyager data help us understand the risks of paclitaxel?

        Marc Bonaca
    6. -

      Paclitaxel safety in patients with CLTI

        Marianne Brodmann
    7. -

      Newly FDA-approved paclitaxel devices for lower extremity and dialysis and the regulatory implications

        Robert Lookstein
    8. -

      New data on paclitaxel in the next couple of years; what should we expect?

        Eva Freisinger
    9. -

      Panel discussion

    10. -

      Paclitaxel vs. limus agents. Mechanism of action, what are the challenges to move beyond paclitaxel?

        Sahil Parikh
    11. -

      Previous experience with limus compounds in the non-coronary arteries; lessons learned

        Thomas Zeller
    12. -

      New limus delivering devices for above and below knee occlusive disease; when to expect results?

        Andrew Holden
    13. -

      Blue horizon keynote speech: Potential for drug delivery in the treatment of lower extremity occlusive disease: what will the practice look like in 5 years?

        Dierk Scheinert
    14. -

      Panel discussion

Cookie settings

We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the website and to manage our corporate commercial objectives, as well as other cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for the display of personalised content. With the exception of strictly necessary cookies, your are free to decide which categories you would like to permit. Please note that depending on the settings you choose, the full functionality of the website may no longer be available. Further information can be found in our privacy statement and cookie policy.

more info
  • Strictly necessary

    We are using cookies in order to enable the services of the website and to ensure that certain aspects work as required. The cookies within this group are essential for the correct appearance and functionality of the website. No information within these cookies will be given to third parties.

  • Analytical (Tracking) Cookies

    We're using functional tracking to analyze the usage of our website. The data hereby gathered, allows us to find errors and improve designs. It also enables us to test the efficacy of our website. These cookies furthermore help us in analyzing our advertisements and affiliate marketing.

  • Functionality Cookies

    Our website makes use of external services such as Issuu and Push-Panda. These services provide great value to us and to you as a user. However they do write cookies and collect data about their usage on this website. In order for you to be able to use these services, you will have to give your consent to their respective cookies.